Cargando…
An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy
We describe the discovery of an agonist of the nuclear receptor NR2F1 that specifically activates dormancy programs in malignant cells. The agonist led to a self-regulated increase in NR2F1 mRNA and protein and downstream transcription of a novel dormancy program. This program led to growth arrest o...
Autores principales: | Khalil, Bassem D., Sanchez, Roberto, Rahman, Tasrina, Rodriguez-Tirado, Carolina, Moritsch, Stefan, Martinez, Alba Rodriguez, Miles, Brett, Farias, Eduardo, Mezei, Mihaly, Nobre, Ana Rita, Singh, Deepak, Kale, Nupura, Sproll, Karl Christoph, Sosa, Maria Soledad, Aguirre-Ghiso, Julio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614154/ https://www.ncbi.nlm.nih.gov/pubmed/34812843 http://dx.doi.org/10.1084/jem.20210836 |
Ejemplares similares
-
5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling
por: Singh, Deepak K., et al.
Publicado: (2023) -
NR2F1 controls tumor cell dormancy via SOX9 and RARβ driven quiescence programs
por: Sosa, Maria Soledad, et al.
Publicado: (2015) -
Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
por: Kim, Ryung S., et al.
Publicado: (2012) -
A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy
por: Di Martino, Julie S., et al.
Publicado: (2022) -
NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients
por: Borgen, Elin, et al.
Publicado: (2018)